Induction of SV40 transplantation antigen (TrAg) during the lytic cycle.
D000818:Animals; D000831:Animals, Newborn; D000941:Antigens / Q000378:metabolism*; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002460:Cell Line; D006224:Cricetinae; D003513:Cycloheximide / Q000494:pharmacology; D003561:Cytarabine / Q000494:pharmacology; D003588:Cytopathogenic Effect, Viral; D003609:Dactinomycin / Q000494:pharmacology; D005260:Female; D005467:Floxuridine / Q000494:pharmacology; D005455:Fluorescent Antibody Technique; D000882:Haplorhini; D007108:Immune Tolerance; D007109:Immunity; D007114:Immunization; D007668:Kidney; D008297:Male; D009374:Neoplasms, Experimental / Q000209:etiology / Q000276:immunology*; D009500:Neutralization Tests; D011691:Puromycin / Q000494:pharmacology; D013539:Simian virus 40 / Q000187:drug effects / Q000254:growth & development / Q000276:immunology* / Q000472:pathogenicity; D013997:Time Factors
D000941:Antigens; D005467:Floxuridine; D003561:Cytarabine; D003609:Dactinomycin; D011691:Puromycin; D003513:Cycloheximide; D001973:Bromodeoxyuridine